Anti-androgens
Showing 26 - 50 of >10,000
Prostate Cancer, Prostate Disease Trial in Tampa (Nivolumab, Brachytherapy, External Beam Radiation Therapy)
Recruiting
- Prostate Cancer
- Prostate Disease
- Nivolumab
- +3 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Nov 11, 2022
Salivary Duct Carcinoma Trial in Nijmegen (Goserelin 10.8 mg, Bicalutamide 50 mg, Dutasteride 0.5 mg)
Not yet recruiting
- Salivary Duct Carcinoma
- Goserelin 10.8 mg
- +2 more
-
Nijmegen, Gelderland, NetherlandsRadboudumc
Aug 23, 2022
Breast Cancer Trial in United States (bicalutamide, diagnostic laboratory biomarker analysis, immunohistochemistry staining
Idiopathic Intracranial Hypertension Trial in Montpellier (Blood punction, Central blood sampling, Intracranial pressure
Not yet recruiting
- Idiopathic Intracranial Hypertension
- Blood punction
- +2 more
-
Montpellier, FranceUniversity Hospital of Montpellier - Gui de Chauliac
Oct 2, 2023
Castration-Sensitive Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Prostate Carcinoma Trial in Seattle
Active, not recruiting
- Castration-Sensitive Prostate Carcinoma
- +7 more
- Antiandrogen Therapy
- +3 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Sep 8, 2022
Congenital Adrenal Hyperplasia (CAH) Trial run by the NICHD (Flutamide, Letrozole, Hydrocortisone)
Active, not recruiting
- Congenital Adrenal Hyperplasia (CAH)
- Flutamide
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Prostate Cancer Trial in United States (abiraterone acetate, Prednisone)
Active, not recruiting
- Prostate Cancer
- abiraterone acetate
- Prednisone
-
Jonesboro, Arkansas
- +204 more
Nov 30, 2022
Prostate Cancer, Castration-resistant Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Baltimore
Recruiting
- Prostate Cancer
- +2 more
- Testosterone Undecanoate
- Enzalutamide
-
Baltimore, MarylandJohns Hopkins Hospital
May 6, 2022
PSA Level Greater Than Two, Stage IV Prostate Adenocarcinoma AJCC v7 Trial in Duarte, South Pasadena (drug, radiation, other)
Active, not recruiting
- PSA Level Greater Than Two
- Stage IV Prostate Adenocarcinoma AJCC v7
- Bicalutamide
- +4 more
-
Duarte, California
- +1 more
Apr 4, 2022
Polycystic Ovary Syndrome Trial in Hull (Survey on patient's perspectives on the development of an structured education
Completed
- Polycystic Ovary Syndrome
- Survey on patient's perspectives on the development of an structured education programme for PCOS
- +4 more
-
Hull, United KingdomHull University Teaching Hospitals NHS Trust, Academic diabetes,
Nov 21, 2021
Preserving Fertility After Colorectal Cancer Study
Recruiting
- Colorectal Cancer
-
Nashville, TennesseeVanderbilt-Ingram Cancer Center
Feb 1, 2022
Clear Cell Renal Cell Carcinoma, Stage I Renal Cell Cancer Trial in New Brunswick (drug, other, procedure)
Terminated
- Clear Cell Renal Cell Carcinoma
- Stage I Renal Cell Cancer
- Enzalutamide
- +2 more
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Sep 14, 2021
Metastatic Hormone-sensitive Prostate Cancer Trial in United States (androgen-deprivation therapy, docetaxel)
Active, not recruiting
- Metastatic Hormone-sensitive Prostate Cancer
- androgen-deprivation therapy
- docetaxel
-
Anchorage, Alaska
- +342 more
Jan 29, 2023
PCOS, NAFLD, NASH Trial in San Francisco, Durham
Recruiting
- PCOS
- +2 more
-
San Francisco, California
- +1 more
Nov 3, 2023
Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Malignant Tumor in the Soft Tissues
Active, not recruiting
- Castration-Resistant Prostate Carcinoma
- +6 more
-
San Francisco, California
- +1 more
Sep 20, 2022
Prostate Cancer Trial in Sacramento (Enzalutamide, Metformin Hydrochloride)
Active, not recruiting
- Prostate Cancer
- Enzalutamide
- Metformin Hydrochloride
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Oct 4, 2022
Polycystic Ovary Syndrome Trial in Birmingham (oral androgen challenge with dehydroepiandrosterone (DHEA))
Recruiting
- Polycystic Ovary Syndrome
- oral androgen challenge with dehydroepiandrosterone (DHEA)
-
Birmingham, West Midlands, United KingdomInstitute of Metabolism and Systems Research
Feb 8, 2022
Castration-resistant Prostate Cancer, Homologous Recombination Deficiency Trial in Sydney (Testosterone Enanthate 100 MG/ML
Recruiting
- Castration-resistant Prostate Cancer
- Homologous Recombination Deficiency
- Testosterone Enanthate 100 MG/ML Injectable Solution
- Testosterone Enanthate 100 MG/ML Injectable Solution / Carboplatin AUC 5
-
Sydney, New South Wales, AustraliaKinghorn Cancer Centre, St. Vincent's Hospital
Dec 16, 2022
Covid19, SARS (Severe Acute Respiratory Syndrome) Trial in Manaus (Proxalutamide, Placebo)
Withdrawn
- Covid19
- SARS (Severe Acute Respiratory Syndrome)
- Proxalutamide
- Placebo
-
Manaus, Amazonas, BrazilSamel Hospital
Feb 17, 2022
Locally Advanced Salivary Gland Carcinoma, Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma Trial
Not yet recruiting
- Locally Advanced Salivary Gland Carcinoma
- +3 more
- Biopsy
- +3 more
- (no location specified)
Jan 10, 2023